Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

Related Articles by Review for PubMed (Select 12915048)

1.

Novel anti-inflammatory therapy for Parkinson's disease.

Gao HM, Liu B, Zhang W, Hong JS.

Trends Pharmacol Sci. 2003 Aug;24(8):395-401. Review.

PMID:
12915048
2.

Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.

Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R.

Curr Pharm Des. 2007;13(18):1925-8. Review.

PMID:
17584117
3.

Novel anti-inflammatory and neuroprotective agents for Parkinson's disease.

Lu L, Li F, Wang X.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):232-40. Review.

PMID:
20015029
5.

Neurodegeneration and inflammation in Parkinson's disease.

Phani S, Loike JD, Przedborski S.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S207-9. doi: 10.1016/S1353-8020(11)70064-5. Review.

PMID:
22166436
6.

Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease.

Whitton PS.

Curr Opin Investig Drugs. 2010 Jul;11(7):788-94. Review.

PMID:
20571974
7.

Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?

Tansey MG, Frank-Cannon TC, McCoy MK, Lee JK, Martinez TN, McAlpine FE, Ruhn KA, Tran TA.

Front Biosci. 2008 Jan 1;13:709-17. Review.

PMID:
17981581
8.

Inflammation in Parkinson's disease.

Tufekci KU, Meuwissen R, Genc S, Genc K.

Adv Protein Chem Struct Biol. 2012;88:69-132. doi: 10.1016/B978-0-12-398314-5.00004-0. Review.

PMID:
22814707
9.

Non-steroidal anti-inflammatory drugs in Parkinson's disease.

Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G.

Exp Neurol. 2007 Jun;205(2):295-312. Epub 2007 Feb 23. Review.

PMID:
17433296
10.

Neuroinflammation in Parkinson's disease.

Hirsch EC, Vyas S, Hunot S.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S210-2. doi: 10.1016/S1353-8020(11)70065-7. Review.

PMID:
22166438
11.

Inflammation as a causative factor in the aetiology of Parkinson's disease.

Whitton PS.

Br J Pharmacol. 2007 Apr;150(8):963-76. Epub 2007 Mar 5. Review.

12.

Inflammation and Parkinson's disease.

Wersinger C, Sidhu A.

Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):221-42. Review.

PMID:
14561187
13.

Neuroprotective strategies in Parkinson's disease : an update on progress.

Mandel S, Gr├╝nblatt E, Riederer P, Gerlach M, Levites Y, Youdim MB.

CNS Drugs. 2003;17(10):729-62. Review.

PMID:
12873156
14.

Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A.

Int Rev Neurobiol. 2007;82:235-46. Review.

PMID:
17678964
15.

Role of cytokines in inflammatory process in Parkinson's disease.

Sawada M, Imamura K, Nagatsu T.

J Neural Transm Suppl. 2006;(70):373-81. Review.

PMID:
17017556
16.

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

Hald A, Lotharius J.

Exp Neurol. 2005 Jun;193(2):279-90. Review.

PMID:
15869932
17.

Glia as a turning point in the therapeutic strategy of Parkinson's disease.

L' Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Marchetti B.

CNS Neurol Disord Drug Targets. 2010 Jul;9(3):349-72. Review.

PMID:
20438439
18.

The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.

Prediger RD, Aguiar AS Jr, Moreira EL, Matheus FC, Castro AA, Walz R, De Bem AF, Latini A, Tasca CI, Farina M, Raisman-Vozari R.

Curr Pharm Des. 2011;17(5):489-507. Review.

PMID:
21375482
19.

A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets.

Ramsey CP, Tansey MG.

Exp Neurol. 2014 Jun;256:126-32. doi: 10.1016/j.expneurol.2013.05.014. Epub 2013 May 28. Review.

PMID:
23726958
20.

Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.

Liu B, Dluzen DE.

Clin Exp Pharmacol Physiol. 2007 Jul;34(7):555-65. Review.

PMID:
17581209
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk